1. Home
  2. TDOC vs XERS Comparison

TDOC vs XERS Comparison

Compare TDOC & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$7.34

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

XERS

Xeris Biopharma Holdings Inc.

HOLD

Current Price

$6.79

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDOC
XERS
Founded
2002
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
TDOC
XERS
Price
$7.34
$6.79
Analyst Decision
Buy
Buy
Analyst Count
18
6
Target Price
$7.56
$10.83
AVG Volume (30 Days)
3.8M
1.4M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
80.58
100.00
EPS
N/A
0.01
Revenue
$2,406,840,000.00
$49,590,000.00
Revenue This Year
$1.19
$34.37
Revenue Next Year
$1.25
$22.86
P/E Ratio
N/A
$693.00
Revenue Growth
18.41
142.67
52 Week Low
$4.40
$4.36
52 Week High
$9.77
$10.08

Technical Indicators

Market Signals
Indicator
TDOC
XERS
Relative Strength Index (RSI) 58.34 66.55
Support Level $6.88 $6.86
Resistance Level $7.39 $7.14
Average True Range (ATR) 0.42 0.25
MACD -0.03 0.08
Stochastic Oscillator 50.93 87.01

Price Performance

Historical Comparison
TDOC
XERS

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Share on Social Networks: